very appropriate technology for mass vaccination , page-16

aryman gday ary , this is an opinion not knowledge. i think merial have had long enough to evaluate the imu products and that is even after their improvements in the promoter,ie expressing 50 times higher.
i think merial are clever and are waiting to see what the ogtr decide before finalising the deal.
i think imu will need to tie this deal up beause sentiment is low and share holders will need something before annual report,other wise it might be a ugly AGM.
holders knowthey might have to wait for other projects to proceed through the pharma stageswhich is a long process in this field.
be under no illusions this is high risk in my opinion, however the upside is very attractive to say the least.
if the bird flu construct trial results come out good it will make global news and it will be whooo$h.
this is my opinion only. do ya own homework andread the red stuff at the bottom.
psi hold imu/